XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. (Nasdaq: XYN) is a biopharmaceutical company focused on the development and commercialization of oncology therapies, primarily targeting the China and global markets. The company filed its S-1 registration statement with the SEC on July 11, 2019 (accession 0001213900-19-012479), marking its entry into the U.S. public markets. Xynomic operates in the pharmaceutical and life sciences sector, with its pipeline centered on licensed oncology assets intended for late-stage clinical development and eventual commercialization. The company has been tracked on SpacDesk as part of broader coverage of biotech and pharmaceutical listings intersecting with the SPAC and special-purpose vehicle ecosystem. Visit SpacDesk and sign up for full filing history, status updates, and data on XYN and hundreds of other tracked companies.